Cap J - Search Results

1

Adrenal venous sampling: where is the aldosterone disappearing to?

Solar M, Ceral J, Krajina A, Ballon M, Malirova E, Brodak M, Cap J. Solar M, et al. Among authors: cap j. Cardiovasc Intervent Radiol. 2010 Aug;33(4):760-5. doi: 10.1007/s00270-009-9722-4. Epub 2009 Oct 1. Cardiovasc Intervent Radiol. 2010. PMID: 19795165 Free PMC article.

2

Adrenal venous sampling in primary aldosteronism: a low dilution of adrenal venous blood is crucial for a correct interpretation of the results.

Ceral J, Solar M, Krajina A, Ballon M, Suba P, Cap J. Ceral J, et al. Among authors: cap j. Eur J Endocrinol. 2010 Jan;162(1):101-7. doi: 10.1530/EJE-09-0217. Epub 2009 Jul 15. Eur J Endocrinol. 2010. PMID: 19605541 Free PMC article.

3

Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.

Cap J, Marekova M, Cerman J, Malirova E, Suba P, Netuka D, Hana V, Marek J. Cap J, et al. Gen Physiol Biophys. 2003 Jun;22(2):201-12. Gen Physiol Biophys. 2003. PMID: 14661732 Free article. Clinical Trial.

4

[Adrenal incidentaloma].

Čáp J, Gabalec F. Čáp J, et al. Vnitr Lek. 2015 Oct;61(10):852-7. Vnitr Lek. 2015. PMID: 26486476 Review. Czech.

5

Cellular cohesiveness in benign and malignant thyroid follicular tumours varies significantly, but the difference is not useful in diagnosis of individual cases.

Rozkos T, Ryska A, Cap J, Sobande F, Laco J. Rozkos T, et al. Among authors: cap j. Cytopathology. 2012 Feb;23(1):39-44. doi: 10.1111/j.1365-2303.2010.00834.x. Epub 2010 Dec 28. Cytopathology. 2012. PMID: 21198996

6

The influence of treatment with somatostatin analogues on morphology, proliferative and apoptotic activity in GH-secreting pituitary adenomas.

Cap J, Cerman J, Nemecek S, Marekova M, Hana V, Frysak Z. Cap J, et al. J Clin Neurosci. 2003 Jul;10(4):444-8. doi: 10.1016/s0967-5868(03)00072-9. J Clin Neurosci. 2003. PMID: 12852883

7

Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas.

Gabalec F, Beranek M, Netuka D, Masopust V, Nahlovsky J, Cesak T, Marek J, Cap J. Gabalec F, et al. Among authors: cap j. Pituitary. 2012 Jun;15(2):222-6. doi: 10.1007/s11102-011-0316-1. Pituitary. 2012. PMID: 21597974

8

Expression profiles of somatostatin, dopamine, and estrogen receptors in pituitary adenomas determined by means of synthetic multilocus calibrators.

Drastikova M, Beranek M, Gabalec F, Netuka D, Masopust V, Cesak T, Marek J, Palicka V, Cap J. Drastikova M, et al. Among authors: cap j. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun;160(2):238-43. doi: 10.5507/bp.2015.058. Epub 2015 Nov 24. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. PMID: 26607296 Free article.

9

Effect of therapeutic doses of ionising radiation on the somatomammotroph pituitary cell line, GH3.

Mareková M, Cáp J, Vokurková D, Vávrová J, Cerman J. Mareková M, et al. Among authors: cap j. Endocr J. 2003 Oct;50(5):621-8. doi: 10.1507/endocrj.50.621. Endocr J. 2003. PMID: 14614219 Free article.

10

The role of apoptosis in pituitary adenomas in the field of conventionally used therapeutic approaches.

Cerman J, Cap J, Marekova M, Nemecek S, Marek J, Rudolf E, Cervinka M. Cerman J, et al. Among authors: cap j. Ann N Y Acad Sci. 2003 Dec;1010:520-4. doi: 10.1196/annals.1299.096. Ann N Y Acad Sci. 2003. PMID: 15033783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page